The risk of cardiovascular events based on the Framingham criteria in Adults Living in Mashhad (Iran)

Authors

  • Malihe Dadgarmoghaddam MD, Assistant Professor of Community Medicine, Community Medicine Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Keywords:

Cardiovascular diseases, Framingham study, Risk factors, Prevention

Abstract

Background and aim: Cardiovascular diseases are a problem in low- and middle-income countries, such as Iran. The present research was performed to identify risk factors contributing to cardiovascular diseases and their distributions among the adult population of Mashhad (Iran) using the Framingham criteria. Methods: This cross-sectional population-based study performed in 2015 on 2,976 adults living in Mashhad (Iran) using Stratified cluster-random sampling method. Demographic information was acquired by surveyors in the research team using a checklist and referring to a medical laboratory for laboratory assessments. The 10-year risk of cardiovascular diseases for the participants was calculated using the Framingham criteria and was classified into three classes: low risk (<10%), intermediate risk (10-20%), and high risk (>20%). The analysis was done by SPSS Version 11.5 by using the Independent-samples t-test, Kruskal-Wallis, and analysis of variance (ANOVA). Results: A total of 2,978 participants aged 16-90 participated in our cross-sectional study with an average age of 43.5±14.7 years. Total risk scores among men and women were 7.29±6.3 and 5.8±6.03, respectively. Compared to women, men exhibited a significantly higher risk of cardiovascular diseases (p<0.001). Average heart age among men and women was estimated at 50.37±18.7 and 48.8±17.0 respectively, i.e. significantly older heart age was obtained for men compared to women (p<0.001).  Conclusion: According to this study, men are at a great risk of cardiovascular events, so we should develop our screening and educational program especially for this population.

References

Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability

and cardiovascular disease risk factors. International journal of cardiology. 2010; 141(2): 122-31. doi:

1016/j.ijcard.2009.09.543.

Members WG, Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, et al. Heart disease and stroke

statistics—2017 update: a report from the American Heart Association. Circulation. 2017; 135(10): e146.

doi: 10.1161/CIR.0000000000000485.

Shahraz S, Forouzanfar MH, Sepanlou SG, Dicker D, Naghavi P, Pourmalek F, et al. Population health and

burden of disease profile of Iran among 20 countries in the region: from Afghanistan to Qatar and Lebanon.

Arch Iran Med. 2014; 17(5): 336-42. doi: 0141705/AIM.006. PMID: 24784862.

Hatmi ZN, Tahvildari S, Motlag AG, Kashani AS. Prevalence of coronary artery disease risk factors in

Iran: a population based survey. BMC cardiovascular disorders. 2007; 7(1): 32. doi: 10.1186/1471-2261-7- 32.

WHO. Cardiovascular diseases (CVDs), Fact sheets. 2016. Available from:

http://www.who.int/mediacentre/factsheets/fs317/en/

Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases part I: general

considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;

(22): 2746-53.

Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in

low-income and middle-income countries. The Lancet. 2007; 370(9603): 1929-38. doi: 10.1016/S0140- 6736(07)61696-1.

Parmley WW. Nonlipoprotein risk factors for coronary heart disease: evaluation and management. Am J

Med. 1997; 102 (2A): 7-14. doi: 10.1016/S0002-9343(97)00461-0.

Corti MC, Guralnik JM, Bilato C. Coronary heart disease risk factors in older persons. Aging (Milano).

; 8(2): 75-89.

Castelli WP, Wilson PW, Levy D, Anderson K. Cardiovascular risk factors in the elderly. Am J Cardiol.

; 63: 16. doi: 10.1080/22201009.2012.10872272.

Toutouzas PK. Gender differences on the risk evaluation of acute coronary syndromes: the CARDIO2000

study. Prev Cardiol. 2003, 6: (2): 71-7. doi: 10.1111/j.1520-037X.2003.01609.x.

Bittner V. Women and coronary heart disease risk factors. J Cardiovasc Risk. 2002; 9: 315-22. doi:

3109/13697130903276422.

Sasaki S, Nakamura K, Uchida A, Fujita H, Itoh H, Nakata T, et al. Blood pressure at health screening as a

predictor of coronary heartdisease in Kyoto. J Cardiovasc Risk. 1996; 3:(1): 77-82. doi:

1177/174182679600300111. PMID: 8783034.

Basile JN. Hypertension 2001: pearls for the clinician. South Med J. 2001; 94: 111054-7. PMID:

Laws A, Reaven GM. Insulin resistance and risk factors for coronary heart disease. Baillieres Clin

Endocrinol Metab. 1993; 7: 1063-78. doi: 10.1016/S0950-351X(05)80245-9.

Haffner SM. Epidemiology of insulin resistance and its relation to coronary artery disease. Am J Cardiol.

; 84: 11-4. doi: 10.1016/S0002-9149(99)00351-3.

Adamopoulos PN, Macrilakis K, Papamichael C, Malakos I, Panayidis N, Moulopoulos SD. Physical

activity and relationship with coronary heart disease risk factors. Acta Cardiol. 1993; 48(6): 523-34. PMID:

Milei J, Grana DR. Mortality and morbidity from smoking- induced cardiovascular disease: The necessity

ofthe cardiologist's involvement and commitment. Int J cardiology. 1998; 67: 95-109. doi: 10.1016/S0167- 5273(98)00248-4. PMID: 9891942.

Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic

review with meta-analysis. BMJ. 2009; 339: b3060. doi: 10.1136/bmj.b3060. PMID: 19690343, PMCID:

PMC2728803.

Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al. Tobacco use and risk of myocardial

infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006; 368: 647–58.

doi: 10.1016/S0140-6736(06)69249-0. PMID: 16920470.

Marshall MR, Ghazipura M, Hossain T, Gordon T, Chen LC. Cardiopulmonary Risk of Waterpipe Smoke:

A Meta-Analysis. Journal of lung Health and Disease. 2018.

Rahmani M, Raiszadeh F, Allahverdian S, Kiaii Sh, Navab M, Azizi F. Coronary artery disease is

associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with

paraoxonase enzyme activity in Iranian subjects. Atherosclerosis. 2002; 162: 381–9. doi: 10.1016/S0021- 9150(01)00715-8.

Haidari M, Moghadam M, Chinicar M, Ahmadieh A, Doosti M. Apolipoprotein B as the best predictor of

coronary artery disease in Iranian normolipidemic patients. Clin Biochem. 2001; 34: 149-55. doi:

1016/S0009-9120(01)00192-8.

Rasouli M, Kiasari AM. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of

metabolic syndrome amplify the predictive values for coronary artery disease. Clinical biochemistry. 2006;

(10): 971-7. doi: 10.1016/j.clinbiochem.2006.07.003.

Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability

and cardiovascular disease risk factors. International journal of cardiology. 2010; 141(2): 122-31. doi:

1016/j.ijcard.2009.09.543.

WHO. Noncommunicable Diseases (NCD) Country Profiles. Iran (Islamic Republic of). Available from:

http://www.who.int/nmh/countries/irn_en.pdf?ua=1

Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of

cardiovascular disease: a historical perspective. Lancet. 2013; 383(9921): 999–1008. doi: 10.1016/S0140- 6736(13)61752-3. PMID: 24084292, PMCID: PMC4159698.

D’agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General

cardiovascular risk profile for use in primary care. Circulation. 2008; 117(6): 743-53. doi:

1161/CIRCULATIONAHA.107.699579. PMID: 18212285.

Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of

multiple-risk-factor assessment equations: a statement for healthcare professionals from the American

Heart Association and the American College of Cardiology. Journal of the American College of

Cardiology. 1999; 34(4): 1348-59. doi: 10.1016/S0735-1097(99)00387-3.

Ichler K, Puhan MA, Steurer J, Bachmann LM. Prediction of first coronary events with the Framingham

score: a systematic review. Am Heart J. 2007; 153(5): 722-31. doi: 10.1016/j.ahj.2007.02.027. PMID:

Bozorgmanesh M, Hadaegh F, Azizi F. Predictive accuracy of the ‘Framingham’s general CVD

algorithm’in a Middle Eastern population: Tehran Lipid and Glucose Study. International journal of clinical

practice. 2011; 65(3): 264-73. doi: 10.1111/j.1742-1241.2010.02529. PMID: 21314863.

Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in

cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies.

Circulation. 2001; 104(23): 2855-64. doi: 10.1161/circ.104.23.2855. PMID: 11733407.

Selvarajah S, Kaur G, Haniff J, Cheong KC, Hiong TG, van der Graaf Y, et al. Comparison of the

Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian

population. International journal of cardiology. 2014; 176(1): 211-8. doi: 10.1016/j.ijcard.2014.07.066.

Meysamie A, Salarvand F, Khorasanizadeh M, Ghalehtaki R, Eskian M, Ghodsi S, et al. Cardiovascular

risk assessment by FRS and SCORE in Iranian adult population. Journal of Diabetes & Metabolic

Disorders. 2017; 16(1): 35. doi: 10.1186/s40200-017-0316-4.

Sarrafzadegan N, Hassannejad R, Marateb HR, Talaei M, Sadeghi M, Roohafza HR, et al. PARS risk

charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region.

PloS One. 2017; 12(12): e0189389. doi: 10.1371/journal.pone.0189389. PMID: 29261727.

Hosseinkhani Z, Ziaee A, Ghorbani A, Javadi A. Distribution of Cardiovascular Disease (CVD) Risk

Factors in Adults in Qazvin City. Medical journal of Mashhad University of Medical Sciences. 2013; 56(5):

-82.

Nasehi MM, Moosazadeh M, Amiresmaeili M, Zakizadeh R, Mirzajani M. Prevalence of five main risk

factors of non-communicable diseases in Mazandaran province: a population based study. Journal of

Mazandaran University of Medical Sciences. 2012; 21(86): 193-202.

Fariba F, Ashari FE, Moradi M. Comparison of Risk Factors Frequency in Patients with ST-elevation MI &

Patients with Non ST-elevation MI in Hamadan City. Scientific Journal of Hamadan University of Medical

Sciences. 2015; 22(1): 11-5.

Tattersall MC, Gangnon RE, Keevil JG. Women Up, Men Down: The Clinical Impact of Replacing the

Framingham Risk Score With the Reynolds Risk Score in the United States Population. doi:

1371/journal.pone.0044347.

Chaves G, Britez N, Munzinger J, Uhlmann L, Gonzalez G, Oviedo G, et al. Education to a healthy

lifestyle improves symptoms and cardiovascular risk factors–AsuRiesgo Study. Arquivos brasileiros de

cardiologia. 2015; 104(5): 347-55. doi: 10.5935/abc.20150021.

Azizi F, Rahmani M, Emami H, Mirmiran PA, Hajipour R, Madjid M, et al. Cardiovascular risk factors in

an Iranian urban population: Tehran lipid and glucose study (phase 1). Sozial-und präventivmedizin. 2002;

(6): 408-26. doi: 10.1007/s000380200008. PMID: 12643001.

Rasouli M, Mohseni Kiasari A, Mokhberi V, Bagheri B, Daneshpour N, Shariati R, et al. Global risk

assessment of coronary heart disease using Framingham's scores for major risk factors. Mazandaran Univ

Med Sci. 2006; 15(50): 49-62.

Sarrafzadegan N, Alikhasi Abda N. Cardiovascular disease situation and-preventive action in Iran. Intern

Symp Ather. 1997; F025

Toutouzas PK. Gender differences on the risk evaluation of acute coronary syndromes: the CARDIO2000

study Prev Cardiol. 2003; 6(2): 71-7.

Bittner V. Women and coronary heart disease risk factors. J Cardiovasc Risk. 2002; 9: 315-22. doi:

1111/j.1520-037X.2003.01609. PMID: 12478200.

Tan YY. Gast GC, van der Schouw YT. Gender differences in risk factors for coronary heart disease.

Maturitas. 2010; 65: 149-160. doi: 10.1016/j.maturitas.2009.09.023.

Kubota Y, Heiss G, MacLehose RF, Roetker NS, Folsom AR. Association of Educational Attainment With

Lifetime Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study. JAMA Intern

Med. 2017; 177(8): 1165-72. doi: 10.1001/jamainternmed.2017.1877. PMID: 28604921, PMCID:

PMC5710437.

Goda A, Demiraj AF, Weidinger F, Metzler B, Ibrahimov F, Pasquet AA, et al. European Society of

Cardiology: cardiovascular disease statistics 2017. European heart journal. 2017. doi:

1093/eurheartj/ehx628.

Eaker, ED. Psychosocial risk factors for coronary heart disease in women. Cardiology Clinic. 1998; 16:

-11. PMID: 9507784.

Herlitz J, Aune S, Claesson A, Svensson L. Epidemiology of cardiac arrest outside and inside hospital

Experiences from registries in Sweden. Signa vitae. 2010; 5(Suppl 1): 44-5.

Ikeda A, Iso H, Toyoshima H, Fujino Y, Mizoue T, Yoshimura T. Marital status and mortality among

Japanese men and women: the Japan collaborative cohort study. BMC Public Health. 2007; 7: 73. doi:

1186/1471-2458-7-73. PMID: 17484786, PMCID: PMC1871578.

Published

2021-12-24